Comparison of the efficacy and safety of miconazole 50 mg mucoadhesive buccal tablets to those of miconazole 500 mg gel in the treatment of oropharyngeal candidiasis: a prospective, randomised, single blind, multicenter, comparative, phase III trial in patients treated with radiotherapy for head and neck cancer

被引：0
|
作者：
Bensadoun, R. -J. [1 ,2 ]
Attali, P. [2 ]
机构：
[1] Ctr Antoine Lacassagne, F-06054 Nice, France
[2] Bio Alliance Pharma, Paris, France
来源：
EJC SUPPLEMENTS | 2007年 / 5卷 / 04期
关键词：
D O I：
10.1016/S1359-6349(07)71232-6
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5515
引用
收藏
页码：328 / 329
页数：2
相关论文
共 6 条
  • [1] Comparison of the efficacy and safety of miconazole 50-mg mucoadhesive buccal tablets with miconazole 500-mg gel in the treatment of oropharyngeal candidiasis -: A prospective, randomized, single-blind, multicenter, comparative, phase III trial in patients treated with radiotherapy for head and neck cancer
    Bensadoun, Rene-Jean
    Daoud, Jamel
    El Gueddari, Brahim
    Bastit, Laurent
    Gourmet, Rene
    Rosikon, Andrzej
    Allavena, Christophe
    Ceruse, Philippe
    Calais, Gilles
    Attali, Pierre
    CANCER, 2008, 112 (01) : 204 - 211
  • [2] A Comparative Randomized, Open-label, Multicenter Study of the Efficacy and Safety of Miconazole Mucoadhesive Tablets and Miconazole Gel in the Treatment of Oropharyngeal Candidiasis [Translated Article]
    Takato, Tsuyoshi
    Kitagawa, Yoshimasa
    Kamikawa, Yoshiaki
    Kishimoto, Hiromitsu
    Nakamura, Seiji
    Komori, Takahide
    Chikazu, Daichi
    Mori, Yoshiyuki
    Tanzawa, Hideki
    Katakura, Akira
    Kanekawa, Akihiro
    Umeda, Masahiro
    Gomi, Akinori
    Yonenaga, Kazumichi
    MEDICAL MYCOLOGY JOURNAL, 2021, 62 (01) : 11 - 19
  • [3] A controlled, multicenter randomised phase 3 study of an extended release miconazole (50 mg) bioadhesive buccal tablet (miconazole Lauriad®) once daily for local treatment of oropharyngeal candidiasis in head and neck cancer patients undergoing radiation therapy
    Bensadoun, RJ
    ANNALS OF ONCOLOGY, 2005, 16 : 318 - 318
  • [4] A controlled, multicenter randomised phase 3 study of an extended release miconazole (50mg) bioadhesive buccal tablet (miconazole Lauriad®) once daily for local treatment of oropharyngeal candidiasis in head and neck cancer patients undergoing radiation therapy
    Bensadoun, R. J.
    Daoud, D.
    Bastit, L.
    El-Gueddari, B.
    Allavena, C.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 66 (03): : S189 - S189
  • [5] Randomized, Comparative, Double-Blind, Double-Dummy, Multicenter Trial of Miconazole Buccal Tablet and Clotrimazole Troches for the Treatment of Oropharyngeal Candidiasis: Study of Miconazole Lauriad® Efficacy and Safety (SMiLES)
    Vazquez, Jose A.
    Patton, Lauren L.
    Epstein, Joel B.
    Ramlachan, Padaruth
    Mitha, Ismail
    Noveljic, Zoja
    Fourie, Jan
    Conway, Brian
    Lalla, Rajesh V.
    Barasch, Andrei
    Attali, Pierre
    HIV CLINICAL TRIALS, 2010, 11 (04): : 186 - 196
  • [6] A controlled, multicenter randomised phase 3 study of an extended release miconazole (50mg) bioadhesive buccal tablet once daily for local treatment of oropharyngeal candidiasis in head and neck cancer patients undergoing radiation therapy.
    Bensadoun, RJ
    Daoud, D
    Bastit, L
    El Gueddari, B
    Allavena, C
    Benidder, A
    Gourmet, R
    Ghabri, S
    Chaumont, C
    Dufour-Lamartinie, JF
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 506S - 506S
1